Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuroplasticity-Based Cognitive Remediation for Chemotherapy-Related Cognitive Impairment

NCT04230863 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT04230863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04230863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuroplasticity-Based Cognitive Remediation for Chemotherapy-Related Cognitive Impairment
Lead sponsor
Vanderbilt University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
February 17, 2020
Completion date
June 30, 2021
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer survivors, chemotherapy-related cognitive impairment